Hinoi Takao, Kawaguchi Yasuo, Hattori Minoru, Okajima Masazumi, Ohdan Hideki, Yamamoto Seiichiro, Hasegawa Hirotoshi, Horie Hisanaga, Murata Kohei, Yamaguchi Shigeki, Sugihara Kenichi, Watanabe Masahiko
Department of Gastroenterological and Transplant Surgery Applied Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan,
Ann Surg Oncol. 2015;22(6):2040-50. doi: 10.1245/s10434-014-4172-x. Epub 2014 Oct 21.
The safety of laparoscopic surgery (LAP) in elderly patients with colorectal cancer has not been demonstrated. The aim of this study was to compare the outcomes of LAP and open surgery (OP) and estimate the feasibility of LAP in colorectal cancer patients aged ≥ 80 years.
We conducted a propensity scoring matched case-control study of colon and rectal cancer patients aged ≥ 80 years using data from 41 hospitals between 2003 and 2007. A total of 1,526 colon cancer patients and 282 rectal cancer patients underwent surgery and were included in the analysis. The primary end point was 3-year overall survival (OS). Secondary end points included disease-free survival (DFS), cancer-specific survival (CSS), and postoperative complications.
LAP and OP were compared in 804 colon cancer patients (402 pairs) and 114 rectal cancer patients (57 pairs) after all covariates were balanced, and no significant differences were observed, except for tumor size in colon cancer. OS, DFS, and CSS did not differ between the groups for either colon cancer (P = 0.916, 0.968, and 0.799, respectively) or rectal cancer (P = 0.765, 0.519, and 0.950, respectively). In colon cancer cases, LAP was associated with fewer morbidities than was OP (24.9 vs. 36.3 %, P < 0.001); no such difference was observed for rectal cancer patients (47.4 vs. 40.4 %, P = 0.450).
LAP is an acceptable alternative to OP in elderly patients with colorectal cancer.
老年结直肠癌患者行腹腔镜手术(LAP)的安全性尚未得到证实。本研究旨在比较LAP与开放手术(OP)的疗效,并评估LAP在≥80岁结直肠癌患者中的可行性。
我们利用2003年至2007年期间41家医院的数据,对≥80岁的结肠癌和直肠癌患者进行了倾向评分匹配病例对照研究。共有1526例结肠癌患者和282例直肠癌患者接受了手术,并纳入分析。主要终点为3年总生存率(OS)。次要终点包括无病生存率(DFS)、癌症特异性生存率(CSS)和术后并发症。
在所有协变量平衡后,对804例结肠癌患者(402对)和114例直肠癌患者(57对)进行了LAP与OP的比较,除结肠癌的肿瘤大小外,未观察到显著差异。结肠癌或直肠癌组之间的OS、DFS和CSS均无差异(结肠癌分别为P = 0.916、0.968和0.799;直肠癌分别为P = 0.765、0.519和0.950)。在结肠癌病例中,LAP的发病率低于OP(24.9%对36.3%,P < 0.001);直肠癌患者未观察到此类差异(47.4%对40.4%,P = 0.450)。
对于老年结直肠癌患者,LAP是OP的可接受替代方案。